FC-MODIFIED WNT SURROGATE MOLECULES AND USES THEREOF

MULTISPECIFIC BINDING CONSTRUCTS AGAINST CHECKPOINT MOLECULES AND USES THEREOF

CLEC12AXCD3 BISPECIFIC ANTIBODIES AND METHODS FOR THE TREATMENT OF DISEASE

ANTI-CD33 ANTIBODIES AND USES THEREOF

SKIN TARGETED IMMUNOTOLERANCE

ANTIBODY AGAINST HUMAN THYMIC STROMAL LYMHEOPOIETIN, METHOD AND APPLICATION

METHODS FOR TREATING HYPERTENSION USING AN ANTI-BMP10 MONOCLONAL ANTIBODY OR FRAGMENT THEREOF

Composition and method for the diagnosis and treatment of iron-related disorders

ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS AND USE THEREOF

BINDING POLYPEPTIDES AGAINST SARS COV-2 AND USES THEREOF

NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

DPEP-1 BINDING AGENTS AND METHODS OF USE

Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders

Human Anti-SOD1 Antibodies

Anti-CD45 antibodies and conjugates thereof

AGONISTIC TNF RECEPTOR BINDING AGENTS

ANTI-CD30L ANTIBODIES AND USES THEREOF

ANTIGEN BINDING MOLECULE SPECIFICALLY BINDING TO RANKL AND NGF, AND MEDICAL USE THEREOF

TIE2 AGONISTIC ANTIBODIES AND USES THEREOF

Anti-CD300LB Antibodies and Methods of Use Thereof

ANTI-TREM-1 ANTIBODIES

ANTIBODIES

Anti-sema3a antibodies and uses thereof

Antibody capable of binding to thymic stromal lymphopoietin and use thereof

PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE

COMPOSITIONS AND METHODS FOR USING BISPECIFIC ANTIBODIES TO BIND COMPLEMENT AND A TARGET ANTIGEN

Human Immunodeficiency Virus Neutralizing Antibodies And Methods Of Use Thereof

MONOCLONAL ANTIBODY 2G1 FOR BROAD-SPECTRUM NEUTRALIZATION OF EBOLA VIRUSES AND APPLICATION THEREOF

AAV FOR THE GENE THERAPY OF WET-AMD

Antigen-Binding Domain

ENGINEERED NON-HUMAN ANIMALS FOR PRODUCING ANTIBODIES

Methods and Compositions for Modulating Beta Chain Mediated Immunity

CLDN18.2 BINDING MOLECULES AND USE THEREOF

HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

ANTIBODY NEUTRALIZING HUMAN RESPIRATORY SYNCYTIAL VIRUS

Method for Delivering Drug to Muscle

FC VARIANT WITH HIGH THERMAL STABILITY AND ATTENUATED EFFECTOR FUNCTION

HUMAN CD163 ANTIBODIES AND USES THEREOF

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

A PLANT PRODUCED ANTI-EGFR MABS WITH SPECIFIC GLYCOSYLATION TO IMPROVE THE EFFICACY AGAINST CANCER

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE OR CYSTEINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT

ANTI-CD3-FOLATE CONJUGATES AND THEIR USES

SIRP α, SIRP β 1, and SIRP γ antibodies and uses thereof

ANTI-TIGIT ANTIBODIES AND THEIR USE

ANTIBODY CONJUGATE COMPRISING ANTI-P-CADHERIN ANTIBODY AND USES THEREOF

MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15)

NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE

Muscle targeting complexes and uses thereof for treating myotonic dystrophy

TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

Antibodies which bind human fibrin or fibrinogen γC domain and methods of use

EPCAM TARGETING TRISPECIFIC PROTEIN FOR TREATMENT OF CANCER

Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias

ANTIBODIES TARGETING BAFF-R AND USE THEREOF

ANTIBODIES TARGETING FLT3 AND USE THEREOF

ANTI-TREM-1 ANTIBODIES AND USES THEREOF

ANTI-ILT4 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS

NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME

ANTIBODIES AGAINST HUMAN TSLP AND USE THEREOF

MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF

ANTI-SEMA3A ANTIBODIES AND THEIR USES FOR TREATING A THROMBOTIC DISEASE OF THE RETINA

ANTI-COMPLEMENT FACTOR BB ANTIBODIES AND USES THEREOF

ANTI-RESPIRATORY SYNCYTIAL VIRUS ANTIBODIES, METHODS OF THEIR GENERATION AND USE

PAN-SPECIFIC CORONA VIRUS BINDERS

SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2

Antibody specific to spike protein of SARS-CoV-2 and uses thereof

ANTI-BK VIRUS ANTIBODY MOLECULES

Chimeric Antigen Receptors with MAGE-A4 Specificity and Uses Thereof

PLASMA KALLIKREIN ANTIBODIES AND USES THEREOF

THERAPEUTIC ANTIBODIES

IMMUNOMODULATORY ANTI-CD73 ANTIBODIES AND USES THEREOF

ANTI-CD40 ANTIBODY AND USE THEREOF

FAP BINDING DOMAINS AND BISPECIFIC BINDING MOIETIES THAT BIND FAP AND TGF-ßRII

FC-REGION VARIANTS WITH MODIFIED FCRN-BINDING PROPERTIES

Anti-yellow fever virus antibodies, and methods of their generation and use

FC-DERIVED POLYPEPTIDES

APRIL AND BAFF INHIBITORY IMMUNOMODULATORY PROTEINS AND METHODS OF USE THEREOF

METHODS FOR EXPANSION OR DEPLETION OF T-REGULATORY CELLS

HETERODIMERIC ANTIBODY FC-CONTAINING PROTEINS AND METHODS FOR PRODUCTION THEREOF

ANTI-BCAM ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF

ANTI-CD20 ANTIBODY COMPOSITIONS

BINDING MOLECULES THAT BIND CD137 AND PD-L1

ANTI-OX40 ANTIBODY, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

METHODS FOR TREATING CANCER USING ANTI-CTLA4 ANTIBODIES

THERAPEUTIC ANTIBODIES

ANTIBODIES AGAINST TIM3 AND USES THEREOF

ANTI-CNTN4-SPECIFIC ANTIBODIES AND USE THEREOF

MULTITARGETING BISPECIFIC ANTIGEN-BINDING MOLECULES OF INCREASED SELECTIVITY

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA)

COTH3 BINDING AGENTS AND USES THEREOF

NEUTRALIZING ANTI-INFLUENZA A ANTIBODIES AND USES THEREOF

ANTIBODIES BINDING TROP2 AND USES THEREOF

IMMUNOMODULATING TRANSGENIC PLANTS AND RELATED METHODS

CD73 (NT5E) TARGETING POLYPEPTIDES

Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies

MULTISPECIFIC PROTEINS COMPRISING AN NKP46-BINDING SITE, A CANCER ANTGIENGE BINDING SITE FUSED TO A CYTOKINE FOR NK CELL ENGAGING

ANTI-AXL ANTIBODIES, ANTIBODY FRAGMENTS AND THEIR IMMUNOCONJUGATES AND USES THEREOF

Anti-IL-23 Antibodies

Anti-IL-27 Antibodies and Uses Thereof

IL-17A BINDING PROTEINS

ANTI-NGF ANTIBODIES AND USES THEREOF

HUMAN ANTIBODY TARGETING COVID-19 VIRUS

Muscle targeting complexes and uses thereof for treating myotonic dystrophy

MULTISPECIFIC PROTEINS

FACTOR XI CATALYTIC DOMAIN-BINDING ANTIBODIES AND METHODS OF USE THEREOF

MESOTHELIN BINDING MOLECULE AND APPLICATION THEREOF

Humanized Anti-CD70 Binding Agents and Uses Thereof

ANTI-HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODY AND PREPARATION METHOD AND APPLICATION THEREOF

IL-1 receptor accessory protein-inhibiting antibodies and antigen-binding fragments thereof

ANTI-ACVR1 ANTIBODIES AND USES THEREOF

ANTI-GALECTIN-9 ANTIBODIES AND THERAPEUTIC USES THEREOF

ANTI-LY6G6D ANTIBODIES AND METHODS OF USE

IMMUNOCYTOKINES AND USES THEREOF

Antigen Binding Proteins that Bind PD-L1

IL-18 Binding Protein (IL-18BP) and Antibodies for Treating Inflammatory Diseases

ANTI-DENGUE VIRUS ANTIBODIES HAVING CROSS-REACTIVITY TO ZIKA VIRUS AND METHODS OF USE

ANTIBODIES FOR SARS-COV-2 AND USES THEREOF

mRNA display antibody library and methods

ANTI-IGE ANTIBODIES

ANTI-MUC1-C ANTIBODIES AND CAR-T STRUCTURES

ANTI-NAPI2B ANTIBODIES AND ANTIBODY-DRUG-CONJUGATES BASED THEREON, THERAPEUTIC METHODS AND USES THEREOF

HYPERGLYCOSYLATED BINDING POLYPEPTIDES

Anti-CCR8 Antibodies and Uses Thereof

THERAPEUTIC INHIBITORS OF GDF15 SIGNALLING

ANTI-PD-1 ANTIBODIES AND USES THEREOF

AMINO ACID SEQUENCES THAT MODULATE THE INTERACTION BETWEEN CELLS OF THE IMMUNE SYSTEM

ANTIBODIES TO TIGIT

CALCIUM VOLTAGE-GATED CHANNEL AUXILIARY SUBUNIT GAMMA 1 (CACNG1) BINDING PROTEINS AND CACNG1-MEDIATED DELIVERY TO SKELETAL MUSCLE

MULTl-CHAIN POLYPEPTIDE-CONTAINING TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS

MODIFIED ANTI-TSLP ANTIBODIES

Multi-Specific Molecules

ANTI-NECTIN-4 ANTIBODY AMANITIN CONJUGATES

ANTI-TIM-3 ANTIBODIES AND METHODS OF USE THEREOF

THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CONJUGATE, SACITUZUMAB GOVITECAN (IMMU-132)

ANTI-CD47 ANTIBODIES AND USES THEREOF

VARIABLE REGIONS FOR NKP46 BINDING PROTEINS

Antibody Constructs for CLDN18.2 and CD3

METHODS OF TREATMENT USING PROTEIN BINDERS TO IRHOM2 EPITOPES

INTERFERON BETA ANTIBODIES AND USES THEREOF

MULTISPECIFIC ANTIBODIES THAT TARGET HPTP-BETA (VE-PTP) AND VEGF

GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF

HUMAN CD33 ANTIBODIES AND GLUCOCORTICOID CONJUGATES

Pharmaceutical compositions comprising anti-human TSLP receptor antibodies and methods of using the same

CONTORSBODY - A SINGLE CHAIN TARGET BINDER

Anti-A2AP antibodies and uses thereof

HLA-RESTRICTED EPITOPES ENCODED BY SOMATICALLY MUTATED GENES

Anti-GDF-15 antibodies

HUMANIZED ANTIBODIES AGAINST PAIRED HELICAL FILAMENT TAU AND USES THEREOF

COMPUTER-BASED METHODS OF DESIGNING PATTERNED MASK

ANTIGEN-BINDING MOLECULES, THE ANTIGEN-BINDING ACTIVITY OF WHICH VARIES ACCORDING TO THE CONCENTRATION OF COMPOUNDS, AND LIBRARIES OF SAID MOLECULES

ANTIBODY THAT BINDS ERBB-2 AND ERBB-3

ANTIBODY THAT BINDS ERBB-2 AND ERBB-3

ANTIGEN-BINDING MOLECULES THAT BIND CD38 AND/OR CD28, AND USES THEREOF

ANTI-HUMAN CXCR5 ANTIBODY AND USES THEREOF

ANTIGEN-BINDING PROTEIN CONSTRUCTS AND ANTIBODIES AND USES THEREOF

ANTI-C1S ANTIBODIES AND USES THEREOF

NS1-BINDING PROTEIN

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

MULTIFUNCTIONAL IMMUNE CELL THERAPIES

COMMON LIGHT CHAIN MOUSE

MONOCLONAL ANTIBODY SPECIFICALLY BINDING TO SUGAR CHAIN IN WHICH A TERMINAL SIALIC ACID RESIDUE IS BOUND TO GALACTOSE WITH ALPHA 2,6 LINKAGE, AND METHOD FOR MEASURING SUGAR CHAIN IN WHICH TERMINAL SIALIC ACID RESIDUE IS BOUND TO GALACTOSE WITH ALPHA 2,6 LINKAGE

Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of use

NON-ACTIVATING ANTIBODY VARIANTS

MESOTHELIN-TARGETED CD40 AGONISTIC MULTISPECIFIC ANTIBODY CONSTRUCTS FOR THE TREATMENT OF SOLID TUMORS

NOVEL DARPIN BASED CD123 ENGAGERS

ANTI-ACVRI ANTIBODIES AND THEIR USE IN THE TREATMENT OF TRAUMA-INDUCED HETEROTOPIC OSSIFICATION

PD-L1-SPECIFIC ANTIBODIES AND METHODS OF USING THE SAME

ANTI-LRP5/6 ANTIBODIES AND METHODS OF USE

ANTI-PAR-2 ANTIBODIES AND METHODS OF USE THEREOF

PAC1 ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS FOR INCREASING TRANSPORT INTO THE BRAIN

METHODS TO IDENTIFY IMMUNOGENS BY TARGETING IMPROBABLE MUTATIONS

CONSTRUCTS COMPRISING SINGLE DOMAIN VHH ANTIBODIES AGAINST SARS COV-2

Anti-coronavirus antibodies and methods of use

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

DLL3 BINDING PROTEINS AND METHODS OF USE

ANTI-MASP-2 ANTIBODY AND USE THEREOF

NOVEL ANTIBODY AGAINST CD55 AND USE THEREOF

ANTIBODIES AGAINST TL1A AND USES THEREOF

Wnt surrogate molecules and uses thereof

ANTI-VISTA CONSTRUCTS AND USES THEREOF

ANTI-TIGIT ANTIBODIES AND METHODS OF USE THEREOF

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

MULTISPECIFIC NKp46 BINDING PROTEINS

ANTI-TIGIT AND ANTI-CD96 ANTIBODIES

ANTIBODY AGAINST NKP46 AND APPLICATION THEREOF

USE OF A PERIOSTIN ANTIBODY FOR TREATING INFLAMMATION, FIBROSIS AND LUNG DISEASES

ANTI-TRANSTHYRETIN ANTIBODIES

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

MONOCLONAL ANTIBODY AGAINST D-DIMER AND DIAGNOSIS AGENT FOR DETECTING D-DIMER, CROSSLINKED FIBRIN AND ITS DERIVATIVES CONTAINING D-DIMER BY USING THE ANTIBODY

Fab-Based Trispecific Antibodies

ANTIBODIES TARGETING FLT3 AND USE THEREOF

LILRB2 ANTIBODY PRODUCTS AND METHODS

ANTIBODIES AGAINST HUMAN TSLP AND USE THEREOF

METHODS OF TREATING HIV-1 INFECTION UTILIZING BROADLY NEUTRALIZING HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) GP120-SPECIFIC MONOCLONAL ANTIBODIES

SINGLE DOMAIN ANTIBODIES THAT NEUTRALIZE SARS-CoV-2

ANTI-BK VIRUS ANTIBODY MOLECULES

HER2/neu-Specific Antibodies and Methods of Using Same

VL ANTIGEN BINDING PROTEINS EXHIBITING DISTINCT BINDING CHARACTERISTICS

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

ANTIBODIES TO IGF2R AND METHODS

LAG-3-Binding Molecules and Methods of Use Thereof

PREPARATION OF SIGLEC-15 BINDING PROTEIN AND USE THEREOF

Anti-Human MSLN Antibody And Application Thereof

MONOCLONAL ANTIBODIES AND USES THEREOF

CD19 BINDERS, CAR-T CONSTRUCTS COMPRISING THE SAME, AND METHODS OF USING THE SAME

POLYPEPTIDES

SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES

Antigen binding proteins specifically binding MAGE-A

CONDITIONALLY ACTIVE ANTI-EPCAM ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES AND USES THEREOF

ANTI-GLP1R ANTAGONIST ANTIBODIES AND METHODS OF USE THEREOF

CD3-DELTA/EPSILON HETERODIMER SPECIFIC ANTIBODIES

ANTIBODIES HAVING SPECIFICITY FOR BTN2 AND USES THEREOF

ANTI-TIGIT ANTIBODIES AND METHODS OF USE

TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE CANCER ANTIGENS

CLDN18.2/CD3 BISPECIFIC ANTIBODIES FOR THE THERAPY OF CLDN18.2-EXPRESSING SOLID TUMORS

GARP Protein Antibody and Use Thereof

BINDING PROTEINS TO THE HUMAN THROMBIN RECEPTOR, PAR4

Modified-IgG antibodies that bind transforming growth factor-β1 with high affinity, avidity and specificity

NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE

TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G

CARDIAC TROPONIN I SPECIFIC ANTIBODY, KIT AND USES THEREOF

METHOD

BROADLY NEUTRALIZING ANTIBODIES AGAINST HIV

Methods and composition for neutralization of influenza

Methods and composition for neutralization of influenza

Methods and composition for neutralization of influenza

Methods and composition for neutralization of influenza

BINDING PROTEIN SPECIFIC FOR THE SPIKE PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2)

HUMANIZED CC CHEMOKINE RECEPTOR 4 (CCR4) ANTIBODIES AND METHODS OF USE THEREOF

HUMANIZED ANTIBODY AGAINST TNFR2 AND USE THEREOF

Canine monoclonal antibodies against canine cytotoxic T lymphocyte associated protein 4 (CTLA-4)

HUMAN CD3 BINDING ANTIBODY

ANTI-SARS-COV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF

NOVEL SLOW-RELEASE PRODRUGS

NON-TERMINAL ANTIBODY DISCOVERY METHODS AND SINGLE CELL ASSAYS

ANTIBODIES TO TICAGRELOR AND METHODS OF USE

DEVELOPMENT OF NEW MONOCLONAL ANTIBODIES RECOGNIZING HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)

Immunomodulatory antibodies and methods of use thereof

ANTI-EGFR NANOBODY AND USE THEREOF

ANTI-FGFR3 ANTIBODY AND USE THEREOF

Anti-FGFR2 Antibody and Use Thereof

BISPECIFIC ANTIBODIES COMPRISING AN NRP1 BINDING DOMAIN AND METHODS OF USE THEREOF

HLA-DR CAR-T COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

DUAL BINDING ANTIBODIES, METHODS OF PRODUCING DUAL BINDING ANTIBODIES, AND USES THEREOF

BINDING AGENTS AND METHODS OF USING THE SAME

Anti-PVRIG antibodies and methods of use

METHODS FOR IDENTIFYING LILRB-BLOCKING ANTIBODIES

ANTI-IL31 ANTIBODIES FOR VETERINARY USE

ANTIBODY THAT BINDS TO VEGF AND IL-1BETA AND METHODS OF USE

HUMAN ANTI-TAU ANTIBODIES

Anti-Gliadin Antibodies

High-Affinity Mycobacterium Tuberculosis Capsule-Specific Human Monoclonal Antibody

MESOTHELIN BINDING PROTEINS

ANTI-VLA-4 ANTIBODIES

ENHANCED HYBRIDOMA GENERATION

Compositions comprising bispecific antibodies to human ADAMTS5 and nerve growth factor

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

IMMUNOMODULATORY ANTIBODIES AND USES THEREOF

CD5-TARGETING FULLY HUMANIZED ANTIBODY

AUTOIMMUNE SUPPRESSOR AND APPLICATION THEREOF

DEPLETION AND INHIBITION OF PLASMACYTOID DENDRITIC CELLS

Antibodies binding to VISTA at acidic pH

BISPECIFIC ANTIBODY

ANTI-SIGLEC-15 ANTIBODY AND APPLICATION THEREOF IN PREPARING DRUG

ANTI-CLEAVED MUTANT CALR-CD3 BISPECIFIC ANTIBODY AND PHARMACEUTICAL COMPOSITION

AN ANTIBODY, A PHARMACEUTICAL COMPOSITION, AND A METHOD

Engineered anti-IL-2 antibodies

CD38-binding proteins comprising de-immunized Shiga toxin A subunit effectors

Compositions and methods for immunotherapy

ANTIBODIES BINDING AXL

Protein S antibodies, methods of making and uses thereof

VARIANT TARGET BINDING AGENTS AND USES THEREOF

METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH PD-1 AND CTLA-4

MULTISPECIFIC BINDING COMPOUNDS THAT BIND TO PD-L1

BISPECIFIC ANTI-CD3 ANTIBODIES, BISPECIFIC ACTIVATABLE ANTI-CD3 ANTIBODIES, AND METHODS OF USING THE SAME

SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS

ANTIBODIES AGAINST CANINE PD-1

ANTI-HUMAN CD22 MONOCLONAL ANTIBODIES AND USE THEREOF

BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD47

Anti-MARCO Antibodies and Uses Thereof

COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES

ANTI-BMP9 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF

HUMAN ANTIBODIES TO BET V 1 AND METHODS OF USE THEREOF

PROTEIN-POLYMER DRUG CONJUGATES

Anti-SIRP-alpha antibodies and methods of use thereof

IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDES

ARRAY-BASED PEPTIDE LIBRARIES FOR THERAPEUTIC ANTIBODY CHARACTERIZATION

MULTISPECIFIC ANTIGEN BINDING PROTEINS

SINGLE DOMAIN ANTIBODIES TARGETING CA-IX AS WELL AS COMPOSITIONS COMPRISING SAME

ENGINEERED ANTIBODIES AND USES THEREOF

ANTI-CD123 BINDING MOLECULES AND USES THEREOF

ANTI-FLT-1 ANTIBODIES FOR TREATING DUCHENNE MUSCULAR DYSTROPHY

ANTI-E-SELECTIN ANTIBODIES, COMPOSITIONS AND METHODS OF USE

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor